This website is intended for UK healthcare professionals only Log in | Register

News and views

December 2020

Women fare worse than men after severe heart attacks

Women face a 20% increased risk of developing heart failure or dying within five years after their first severe heart attack compared with men, according to new US research published in Circulation (DOI: 10.1161/CIRCULATIONAHA.120.048015). In addition, women were more likely than men to be older and have a more complicated medical history at the time of their heart attacks....

December 2020

Dapagliflozin approved in the EU for heart failure

AstraZeneca’s sodium-glucose co-transporter-2 (SGLT2 inhibitor) dapagliflozin has been approved in the European Union (EU) for the treatment of symptomatic chronic heart failure with reduced ejection fraction in adults with and without type 2 diabetes....

December 2020

Urgent call for more heart failure nurses

The number of specialist heart failure nurses should be increased from one to four for every 100,000 people to meet the growing demand from a rising number of heart failure cases, according to a new report from the Alliance for Heart Failure....

December 2020

Professors Peter Sleight and Tony Gershlick

We report with great sadness, the deaths of two very distinguished cardiologists: Professors Peter Sleight (Oxford University) and Anthony (Tony) Gershlick (University of Leicester). Their contributions to cardiovascular medicine have been immense and they will be greatly missed. Our sincere condolences go to their families and many friends and colleagues....

December 2020

Sacubitril-valsartan benefits in cancer therapy-related cardiac dysfunction

A study from Argentina has assessed the effectiveness of sacubitril-valsartan in patients with cancer therapy-related cardiac dysfunction (CTRCD) treated in cardio-oncology units (DOI: 10.1186/s40959-020-00078-4). The study was carried out in 635 breast cancer patients. Some 51 patients developed CTRCD, and of these, 28 were available for analysis. Most of the patients were women and treated with doxorubicin/cyclophosphamide or trastuzumab/pertuzumab....

December 2020

Inclisiran data shows good results LDL-C reduction across race and gender

Results from phase 3 studies with Inclisiran, a potential first-in-class small interfering RNA (siRNA) agent, have shown that it is well-tolerated and provides effective and sustained reduction in low-density lipoprotein cholesterol (LDL-C) when used in addition to other lipid-lowering therapies regardless of patients’ age and gender....

December 2020

What should nanny do next? The government and obesity

Obesity in the UK is on the up. Prevalence of obesity is higher in more deprived communities, and it is linked to a range of health conditions – as well as increasing a person’s risk from COVID-19. The pandemic has moved tackling obesity higher up the government’s agenda....

September 2020 Br J Cardiol 2020;27:79

Joint BACPR/BDA/PHNSG statement on nutrition and cardiovascular health post-COVID-19 pandemic

The British Association for Cardiovascular Prevention and Rehabilitation (BACPR), the British Dietetic Association (BDA) and the Public Health Nutrition Specialist Group (PHNSG) have issued a joint statement on nutrition and cardiovascular health post-COVID-19 pandemic. We publish the statement here in full....

August 2020

Obituary: Dr Michael Schachter

We were shocked to hear the sad news of a dear friend passing away, Dr Michael Schachter (Senior Lecturer in Clinical Pharmacology, National Heart and Lung Institute, Imperial College London) who has profoundly impacted the lives of many students, colleagues and patients. He was also a much-valued member of the BJC editorial board....

June 2020 Online First

COVID-19 bulletin 3: clinical practice in the pandemic

Welcome to the third of our COVID-19 bulletins, which we hope will help you filter the continual stream of information published in both the lay and specialist press. Our Bulletins aim to present aspects important for your practice. We have joined with the Cardiorenal Forum, the British Society for Heart Failure, the British Geriatrics Society Cardiovascular Section and other medical and nursing groups to achieve this....

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now